Recently the World Health Organization (WHO) approved several biological drugs to treat COVID-19 disease. This is the first time that the organisation has moved so quickly to list monoclonal antibodies, popularly called mAbs, for the treatment of a disease. But will they reach the patients who need them?

If so, you have a moment right now to stand by the millions of unvaccinated people across the world by demanding that US pharmaceutical corporation, Moderna, urgently shares its COVID-19 vaccine recipe – which was predominantly funded by the public.